The relationship between gastric sleeve surgery and type 2 diabetes is one of the most clinically significant areas in bariatric medicine. For people living with type 2 diabetes, surgery can produce outcomes that medication alone rarely achieves. Here is what the evidence shows and what we observed in our own experience after our procedures in March 2024.
What happens to blood sugar immediately after surgery
One of the most striking findings in bariatric research is that improvements in blood sugar control begin within days of surgery, before meaningful weight loss has occurred. This cannot be explained by reduced calorie intake alone. A significant part of the effect is hormonal.
The sleeve removes the fundus of the stomach, which is heavily involved in ghrelin secretion. Beyond this, surgery alters the release of gut hormones including GLP-1, which plays a key role in stimulating insulin secretion and improving insulin sensitivity. These changes happen rapidly, which is why blood glucose levels can normalise or dramatically improve in the days immediately following surgery even when weight loss is minimal.
Remission rates
The research on type 2 diabetes remission following sleeve gastrectomy is consistent. Studies show remission rates of 50 to 70 percent at one year, meaning blood glucose levels return to the normal range without ongoing medication. At five years, remission rates are lower as some people experience recurrence, but they remain substantially higher than what is achievable through lifestyle intervention or medication management alone in comparable patient groups.
For context, the landmark DiRECT trial, which looked at intensive dietary intervention in a primary care setting, achieved remission in around 46 percent of participants at one year. Surgery consistently matches or exceeds this in comparable populations, with the added benefit of sustained restriction supporting long-term maintenance.
Factors that predict better outcomes
Shorter duration of diabetes before surgery is associated with better remission rates. People who have had type 2 diabetes for less than five years and who are not yet on insulin tend to do better than those with longer disease duration or more advanced beta cell failure. This suggests that surgery is most effective when the underlying insulin-producing capacity of the pancreas is still intact and capable of recovery once the metabolic environment improves.
What we experienced
James entered surgery with pre-diabetic markers rather than confirmed type 2 diabetes. Within three months, those markers had fully normalised alongside blood pressure and his liver function. The speed of that metabolic correction was striking, particularly the liver function, which returned to normal within three weeks. Kirsten, who has Crohn’s disease and a more complex metabolic picture, also saw her metabolic markers improve in the months following surgery.
Neither of us was on diabetic medication before surgery. For people who are, the medication picture needs careful management in the post-operative period. Hypoglycaemia, abnormally low blood sugar, is a genuine risk if diabetic medications are continued at pre-operative doses when the stomach is restricted and calorie intake has dropped sharply. Medication adjustment needs to happen quickly and should be overseen by the clinical team.
Does the improvement last?
For many people, yes. Five and ten year follow-up data shows that a meaningful proportion of patients maintain diabetes remission long term, particularly those who maintain their weight loss and continue to follow a healthy diet and exercise pattern. For others, blood sugar levels drift upward over time, particularly if weight is regained. Surgery addresses the metabolic environment but does not prevent diabetes from returning if the underlying lifestyle factors are not sustained.
Sources
NHS: Weight loss surgery. NICE: Obesity: identification, assessment and management (NG238). BOMSS: Metabolic outcomes of bariatric surgery. Lean MEJ et al: Primary care-led weight management for remission of type 2 diabetes (DiRECT). The Lancet 2018. Schauer PR et al: Bariatric surgery versus intensive medical therapy for diabetes. NEJM 2017.
About this content
This blog is written by James and Kirsten, a couple from the UK who had gastric sleeve surgery together in March 2024.
We started this blog because we couldn't find any sources of content that details before surgery, the surgery and then life post surgery - so we decided to write one ourselves.
Everything on this site is based on our own experience and the research we have done along the way. It is not medical advice. Gastric sleeve surgery is a serious procedure and every patient's journey is different. Please always consult your own bariatric team or GP before making any decisions about your health or treatment.
Some posts on this site may contain featured or sponsored content, or affiliate links. Where this is the case, it will always be clearly stated at the top of the article. Our opinions are always our own.
Publish Date: 4 June 2026 | Last Reviewed: 7 June 2026 | Next Planned Review: 7 December 2027